dict.md logo
Results for S in English, page 481
Survanta
Survanta 25 MG/ML Endotracheal Suspension
Survanta 25 MG/ML Injectable Suspension
Survanta Intratracheal
Survanta Intratracheal 25 MG/ML Injectable Suspension
Survanta Intratracheal, 25 mg/ml intratracheal solution
Survanta Intratracheal, 25 mg/mL intratracheal suspension
Survector
surveillance
surveillance aspects
surveillance authority
Surveillance Bias
surveillance camera
surveillance cameras
SURVEILLANCE IMMUNOL
Surveillance Implementation Group
Surveillance Methods
Surveillance Modeling
Surveillance of previously prescribed contraceptive methods
Surveillance Program
Surveillance Program, Hazard
Surveillance Programs, Hazard
Surveillance Research Program
surveillance state
Surveillance, Epidemiology, and End Results (SEER) Program
Surveillance, Epidemiology, and End Results Program
Surveillance, Epidemiology, and End Results Program (SEER)
Surveillance, Immunologic
Surveillance, Immunological
Surveillance, Population
Surveillance, Post-Marketing Product
Surveillance, Postmarketing Drug
Surveillance, Postmarketing Product
Surveillance, Public Health
Surveillance, Sentinel
surveillances
Surveillances, Immunologic
Surveillances, Immunological
Surveillances, Post-Marketing Product
Surveillances, Postmarketing Drug
Surveillances, Postmarketing Product
Surveillances, Sentinel
Survey
survey (of maps)
Survey Acre
Survey Administration
survey by area covered
survey data
SURVEY DEMOGR
SURVEY DENT HEALTH
Survey Foot
Survey Inch
Survey Instrument
Survey instruments
Survey Method
SURVEY METHODOL
Survey Methodology
Survey Methods
Survey Mil
Survey Mile
survey of a country
survey of buildings and site
survey of research
survey of site
survey of water bodies
Survey Personnel
survey plan
Survey reporting period end date
Survey reporting period end date | Facility
Survey reporting period end date Facility
Survey reporting period end date:Time Stamp -- Date and Time:Point in time:Facility:Quantitative
Survey reporting period end date:TmStp:Pt:Facility:Qn
Survey reporting period start date
Survey reporting period start date | Facility
Survey reporting period start date Facility
Survey reporting period start date:Time Stamp -- Date and Time:Point in time:Facility:Quantitative
Survey reporting period start date:TmStp:Pt:Facility:Qn
survey research
survey result
survey results
Survey Shared Resource
Survey Yard
Survey Yard US
Survey, Abortion
Survey, Baseline
Survey, Community
Survey, Contraceptive Prevalence
Survey, Cross-Sectional
Survey, Demographic
Survey, Dental Health
Survey, Diet
Survey, Disease Frequency
Survey, Family Life
Survey, Health
Survey, Health Care
Survey, Healthcare
Survey, Library
Survey, Longitudinal
Survey, Nutrition
Survey, Nutritional
Survey, World Fertility
SURVEY.CARE
SURVEY.GDS
SURVEY.HOWRU
SURVEY.MDS
SURVEY.NMMDS
SURVEY.NURSE.HHCC
SURVEY.NURSE.HIV-SSC
SURVEY.NURSE.LIV-HIV
SURVEY.NURSE.OMAHA
SURVEY.NURSE.QAM
SURVEY.OASIS
SURVEY.PHQ
SURVEY.QRDA
SURVEY.RFC
SURVEY.USSG-FHT
SURVEY.USSGFHT
surveyed
surveyest
surveyeth
surveying
Surveying (process)
surveying apparatus
surveyor
surveyor (of mines)
Surveyor's Chain British
Surveyor's Chain USA
surveyor's rod
surveyor's rods
surveyor's table
surveyor's tables
surveyors
surveyors' arrow
surveyors' arrows
Surveys
SURVEYS DEMOGR
SURVEYS DENT HEALTH
SURVEYS DIS FREQUENCY
Surveys, Abortion
Surveys, Baseline
Surveys, Community
Surveys, Contraceptive Prevalence
Surveys, Cross-Sectional
Surveys, Demographic
Surveys, Dental Health
Surveys, Diet
Surveys, Disease Frequency
Surveys, Family Life
Surveys, Health
Surveys, Health Care
Surveys, Healthcare
Surveys, Library
Surveys, Longitudinal
Surveys, Nutrition
Surveys, Nutritional
Surveys, World Fertility
survivability
survivable
Survival
SURVIVAL ANAL
Survival Analyses
Survival Analysis
Survival Analysis Technique
survival aspects
survival cell
survival cells
Survival Curves, Kaplan-Meier
SURVIVAL DIS FREE
Survival Factors (Apoptosis)
Survival greater than one year rare
survival kit
survival knife
survival modeling
survival motor neuron 1 protein, mouse
Survival motor neuron 1 protein, rat
survival motor neuron 1 protein, zebrafish
survival motor neuron complex
survival motor neuron complex location
survival motor neuron domain containing 1
survival motor neuron domain containing 1 protein, human
Survival Motor Neuron Protein 1
Survival Motor Neuron Protein 2
survival motor neuron protein, Drosophila
survival of motor and autonomic neurons 1
Survival of Motor Neuron 1 Protein
SURVIVAL OF MOTOR NEURON 1, TELOMERIC
Survival of Motor Neuron 1, Telomeric Protein
survival of motor neuron 1, telomeric protein, human
survival of motor neuron 1, telomeric protein, rat
Survival of Motor Neuron 2 Protein
SURVIVAL OF MOTOR NEURON 2, CENTROMERIC
Survival of Motor Neuron 2, Centromeric Protein
survival of motor neuron 2, centromeric protein, human
Survival of Motor Neuron 3, Centromeric Protein
Survival of Motor Neuron Complex
Survival of Motor Neuron Complex Proteins
survival of motor neuron protein interacting protein 1
survival of motor neuron protein interacting protein 1, human
Survival of Motor Neuron Protein-Interacting Protein 1
SURVIVAL OF MOTOR NEURON-RELATED PROTEIN
survival of motor neuron-related splicing factor 30 protein, human
survival of the fittest
Survival past infancy is rare
survival promoting peptide
survival protein, E coli
Survival quality
Survival quality | Cancer XXX
Survival quality Cancer
Survival quality:Type:Point in time:Cancer.To be specified in another part of the message:Nominal
Survival quality:Type:Pt:Cancer.XXX:Nom
Survival Rate
Survival Rate, Cumulative
Survival Rates
Survival Rates, Cumulative
survival related gene
survival species
survival strategies
survival strategy
Survival Technology Brand of Atropine
Survival Time, Mean
Survival Times, Mean
Survival to 10 years
Survival to 20 years in severe form
Survival to 20s-60s in IIB
Survival to 5-15 years of age
survival training
SURVIVAL-RELATED GENE
survival-related gene product, human
survival-related gene product, mouse
Survival, Cell
Survival, Disease Free
Survival, Disease-Free
Survival, Erythrocyte
Survival, Event-Free
Survival, Graft
Survival, Organ
Survival, Progression-Free
Survival, Tissue
survivalism
survivalist
Survivals, Disease-Free
Survivals, Event-Free
Survivals, Graft
Survivals, Progression-Free
survive
survived
survives
survivest
surviveth
survivin
survivin 1 protein, zebrafish
survivin antigen
survivin in Xenopus protein, Xenopus
survivin inhibitor YM155
survivin peptide vaccine
survivin protein, human
survivin protein, mouse
survivin protein, rat
Survivin Sur1M2 Peptide Vaccine
survivin variant 3 alpha
survivin-2B protein, human
survivin-deltaEx3, human
survivin2 protein, zebrafish
surviving
surviving dependant
surviving dependants
Survivor
survivor of motor neuron protein interacting protein 1, mouse
Survivor, AIDS Long-Term
Survivor, Cancer
Survivor, HIV Long-Term
Survivor, HIV-1 Long-Term
Survivor, Long-Term
Survivors
Survivors develop dysautonomia-like symptoms
Survivors have mental retardation, spasticity, and adducted thumbs (MASA syndrome findings ({303350})
Survivors may develop renal insufficiency and hepatic dysfunction
Survivors, AIDS Long-Term
Survivors, HIV Long-Term
Survivors, HIV-1 Long-Term
Survivors, Long-Term
Survivorship
survivorship annuity
survivorship curve
Survivorship Issues
Survivorship, Cancer
Sus
SUS 316L
Sus amntc cav/mem nt fnd
Sus barbatus
Sus bucculentus
Sus cebifrons
Sus celebensis
Sus cervcl shortn nt fnd
Sus fetal anomaly nt fnd
Sus fetal growth not fnd
Sus philippensis
Sus philippensis x Sus barbatus
Sus placentl prob nt fnd
Sus salvanius
Sus scrofa
Sus scrofa domestica
SUS SCROFA HAIR
SUS SCROFA HAIR .05 GM/ML INTRADERMAL INJECTION, SOLUTION [HOG]
SUS SCROFA HAIR .05 GM/ML SUBCUTANEOUS INJECTION, SOLUTION [HOG]
SUS SCROFA HAIR 0.05 g in 1 mL INTRADERMAL INJECTION, SOLUTION
SUS SCROFA HAIR 0.05 g in 1 mL SUBCUTANEOUS INJECTION, SOLUTION
SUS SCROFA HAIR 0.05 GM/ML INTRADERMAL INJECTION, SOLUTION [HOG]
SUS SCROFA HAIR 0.05 GM/ML SUBCUTANEOUS INJECTION, SOLUTION [HOG]
SUS SCROFA HAIR 0.1 g in 1 mL INTRADERMAL INJECTION, SOLUTION
SUS SCROFA HAIR 0.1 g in 1 mL SUBCUTANEOUS INJECTION, SOLUTION
SUS SCROFA HAIR 0.1 GM INTRADERMAL INJECTION, SOLUTION [HOG]
SUS SCROFA HAIR 0.1 GM SUBCUTANEOUS INJECTION, SOLUTION [HOG]
Sus scrofa hair extract 0.05 GM/ML Injectable Solution
Sus scrofa hair extract 0.1 GM/ML Injectable Solution
Sus scrofa hair extract 100 MG/ML Injectable Solution
Sus scrofa hair extract 50 MG/ML Injectable Solution
Sus scrofa papillomavirus type 1
SUS SCROFA SKIN
SUS SCROFA SKIN 0.05 g in 1 mL INTRADERMAL INJECTION, SOLUTION
SUS SCROFA SKIN 0.05 g in 1 mL SUBCUTANEOUS INJECTION, SOLUTION
SUS SCROFA SKIN 0.1 g in 1 mL INTRADERMAL INJECTION, SOLUTION
SUS SCROFA SKIN 0.1 g in 1 mL SUBCUTANEOUS INJECTION, SOLUTION
SUS SCROFA SKIN 1 g in 20 mL CUTANEOUS INJECTION
SUS SCROFA SKIN 1 g in 20 mL INTRADERMAL INJECTION
SUS SCROFA SKIN 1 g in 20 mL SUBCUTANEOUS INJECTION
SUS SCROFA SKIN 1 GM INTRADERMAL INJECTION [HOG]
SUS SCROFA SKIN 1 GM SUBCUTANEOUS INJECTION [HOG]
SUS SCROFA SKIN 10000 [PNU] in 1 mL INTRADERMAL INJECTION, SOLUTION
SUS SCROFA SKIN 10000 [PNU] in 1 mL SUBCUTANEOUS INJECTION, SOLUTION
SUS SCROFA SKIN 20000 [PNU] in 1 mL INTRADERMAL INJECTION, SOLUTION
SUS SCROFA SKIN 20000 [PNU] in 1 mL SUBCUTANEOUS INJECTION, SOLUTION
Sus scrofa skin extract 0.05 GM/ML Injectable Solution
Sus scrofa skin extract 0.1 GM/ML Injectable Solution
Sus scrofa skin extract 100 MG/ML Injectable Solution
Sus scrofa skin extract 10000 UNT/ML Injectable Solution
Sus scrofa skin extract 20000 UNT/ML Injectable Solution
Sus scrofa skin extract 50 MG/ML Injectable Solution
Sus sp.
Sus sp. GDAC01
Sus sp. GL
Sus sp. P06
Sus sp. PCIMan002
Sus sp. PPNGMu01
Sus sp. PRFSSF3002
Sus verrucosus
SUS-316L
Sus-Phrine Injection
Sus-Phrine Injection 5 MG/ML Injectable Suspension
Sus-Phrine Injection, 5 mg/mL subcutaneous suspension
SUS1 protein, Arabidopsis
Sus1 protein, S cerevisiae
SUS316L
Susac Syndrome
Susac's Syndrome
Susacs Syndrome
Susadrin
susalimod
Susan
Susan G Komen Breast Cancer Foundation
Susana
Susana annulata
Susana annulata Smith
Susanna
Susannah
Susanomira
Susanomira caucasica
Susanomira caucasica Pont, 1987
Susanville
Susanville Indian Rancheria, California
Susanville Indians
Susc
Susc Meth XXX
Suscard
Suscard 1 MG Sustained Release Buccal Tablet
Suscard 2 MG Sustained Release Buccal Tablet
Suscard 3 MG Sustained Release Buccal Tablet
Suscard 5 MG Sustained Release Buccal Tablet
susceptance
Susceptibilities, Disease
Susceptibilities, Genetic
Susceptibility
Susceptibility (property) (qualifier value)
Susceptibility associated with mutation in the mucin 3 gene (MUC3A, {158371})
Susceptibility conferred by 9-SNP haplotype in malic enzyme 2 (ME2, {154270.0001})
Susceptibility conferred by allele 2 of the dinucleotide repeat in the dopamine receptor DRD5 gene ({126453.0001})
Susceptibility conferred by mutation in the butyrophilin-like protein 2 gene (BTNL2, {606000.0001})
Susceptibility conferred by mutation in the dopamine receptor D3 gene (DRD3, {126451.0001})
Susceptibility conferred by mutation in the dynactin 1 gene (DCTN1, {601143.0002})
Susceptibility conferred by mutation in the factor I gene (CFI, {217030.0004})
Susceptibility conferred by mutation in the interferon regulatory factor 6 gene (IRF6, {607199.0013})
Susceptibility conferred by mutation in the major histocompatibility complex, class I, B gene (HLA-B, {142830.0001})
Susceptibility conferred by mutation in the major histocompatibility complex, class I, C gene (HLA-C, {142840.0001})
Susceptibility conferred by mutation in the major histocompatibility complex, class II, DR beta-1 gene (HLA-DR1B, {142857.0001})
Susceptibility conferred by mutation in the methyl-CpG binding protein-2 gene (MECP2, {300005.0011})
Susceptibility conferred by mutation in the neurofilament, heavy polypeptide gene (NEFH, {162230.0001})
Susceptibility conferred by mutation in the neuroligin-3 gene (NLGN3, {300336.0001})
Susceptibility conferred by mutation in the neuroligin-4 gene (NLGN4, {300427.0001})
Susceptibility conferred by mutation in the nucleotide-binding oligomerization domain protein 2 gene (NOD2, {605956.0001})
Susceptibility conferred by mutation in the paired box gene 4 (PAX4, {167413.0022} )
Susceptibility conferred by mutation in the peripherin gene (PRPH, {170710.0001})
Susceptibility conferred by mutation in the promoter of the nitric oxide synthase-1 gene (NOS1, {163731.0001})
Susceptibility conferred by mutations in the alpha-2-macroglobulin gene (A2M, {103950.0005})
Susceptibility conferred by mutations in the angiotensin I converting enzyme gene (ACE, {106180.0001})
Susceptibility conferred by mutations in the asporin gene (ASPN, {608135.0001})
Susceptibility conferred by mutations in the bleomycin hydrolase gene (BLMH, {602403.0001})
Susceptibility conferred by mutations in the frizzled-related protein gene (FRZB, {605083.0001})
Susceptibility conferred by mutations in the homolog of the S. pombe checkpoint kinase 2 gene (CHEK2, {604373.0007})
Susceptibility conferred by mutations in the matrilin-3 gene (MATN3, {602109.0003})
Susceptibility conferred by mutations in the MHC class II transactivator gene (MHC2TA, {600005.0007})
Susceptibility conferred by mutations in the protein tyrosine phosphatase, receptor type, c polypeptide gene (PTPRC, {151460.0001})
Susceptibility conferred by polymorphisms in the brain-derived neurotrophic factor gene (BDNF, {113505.0002} and {113505.0003})
SUSCEPTIBILITY DENT CARIES
SUSCEPTIBILITY DIS
Susceptibility Gene
SUSCEPTIBILITY GENET
Susceptibility method
Susceptibility method [Identifier]
Susceptibility method | XXX
Susceptibility method:Presence or Identity:Point in time:To be specified in another part of the message:Nominal:*
Susceptibility method:Prid:Pt:XXX:Nom:*
Susceptibility methods
Susceptibility order set
Susceptibility order sets
Susceptibility organism
Susceptibility organism^^^4:Presence or Identity:Point in time:To be specified in another part of the message:Nominal
Susceptibility organism^^^4:Prid:Pt:XXX:Nom
Susceptibility Panels
Susceptibility skin test
SUSCEPTIBILITY TEST CARDS, ANTIMICROBIAL
SUSCEPTIBILITY TEST DISCS, ANTIMICROBIAL
SUSCEPTIBILITY TEST POWDERS, ANTIMICROBIAL
SUSCEPTIBILITY TEST POWDERS, ANTIMYCOBACTERIAL
Susceptibility Testing
Susceptibility to chickenpox
SUSCEPTIBILITY TO COLON CANCER 1, MOUSE, HOMOLOG OF
susceptibility to cracking
Susceptibility to fracture
Susceptibility to infection
Susceptibility to infection by Mycobacterium leprae causing leprosy
Susceptibility to infections start in the first year of life
Susceptibility to infections starts in the first week of life
SUSCEPTIBILITY TO LYSIS BY ALLOREACTIVE NATURAL KILLER CELLS
SUSCEPTIBILITY TO LYSIS BY ALLOREACTIVE NATURAL KILLER CELLS (finding)
susceptibility to natural killer cell mediated cell death
susceptibility to natural killer cell mediated cell killing
susceptibility to natural killer cell mediated cytolysis
susceptibility to natural killer cell mediated cytotoxicity
susceptibility to NK cell mediated cell death
susceptibility to NK cell mediated cell killing
susceptibility to NK cell mediated cytolysis
susceptibility to NK cell mediated cytotoxicity
Susceptibility to rage in 50% of patients
Susceptibility to respiratory infections
Susceptibility to septic shock due to mutations in the tumor necrosis factor (TNF, {191160.0003})
Susceptibility to SLE caused by mutations in the receptor for Fc fragment of IgG, low affinity IIa gene (FCGR2A, {146790.0001})
Susceptibility to SLE caused by mutations in the tumor necrosis factor ligand superfamily, member 6 gene (TNFSF6, {134638.0001})
susceptibility to T cell mediated cytotoxicity
SUSCEPTIBILITY TO, CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 4
Susceptibility, Dental Caries
Susceptibility, Disease
Susceptibility, Genetic
Susceptibility/Resistance Gene
Susceptibilty to cerebral malaria due to mutations in the tumor necrosis factor (TNF, {191160.0002})
susceptible
susceptible (to)
susceptible to faults
Susceptible to hyperthermia
Susceptible to vaccine-induced polio
Susceptible. Indicates for microbiology susceptibilities only.
susceptibleness
susceptibly
susception
susceptive
susceptively
SUSD1 gene
SUSD2 gene
SUSD2 protein, mouse
SUSD2P1 gene
SUSD2P2 gene
SUSD3 gene
SUSD4 gene
SUSD5 gene
sushi
Sushi Domain
sushi domain containing 1
sushi domain containing 2
sushi domain containing 2 pseudogene 1
sushi domain containing 2 pseudogene 2
sushi domain containing 3
sushi domain containing 4
sushi domain containing 5
SUSHI REPEAT PROTEIN UPREGULATED IN LEUKEMIA
SUSHI REPEAT-CONTAINING PROTEIN, X-LINKED
SUSHI REPEAT-CONTAINING PROTEIN, X-LINKED, 2
Sushi-Repeat Containing Protein
Sushi-Repeat Protein
Sushi-Repeat Protein Upregulated in Leukemia, human
sushi-repeat protein, human
sushi-repeat-containing protein, mouse
479 480 481 482 483